Enter your terms above and click the 'Search' button.

Showing articles 0 to 1 of 1 Filter Applied: intrathecal medication (Click to remove) Intrathecal 2-hydroxypropyl-�-cyclodextrin Decreases Neurological Disease Progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial Lancet 390:1758-1768, Ory, D.S.,et al, 2017 Showing articles 0 to 1 of 1